US Food and Drug Administration Pushed to Change
Lancet 2006 May 20-26; 367(9523): 1643-1644
Showing items related by title, author, creator and subject.
McCarthy, Michael (2002-06-15)
FDA [Food and Drug Administration] recommends bringing controversial IBS [irritable bowel syndrome] drug back [Alosetron] McCarthy, Michael (2002-04-27)
McCarthy, Michael (2002-08-24)